Evidence map›Paper›PMID 32613561›Full record

ArticlePathology oncology research : POR2020

Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids.

Viktoria Koroknai, Vikas Patel, István Szász, Róza Ádány, Margit Balazs

Open access · hybridAbstract read
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Viktoria KoroknaiPublic Health Research Institute, University of Debrecen, Kassai St 26/B, Debrecen, H-4028, Hungary.
Vikas PatelPublic Health Research Institute, University of Debrecen, Kassai St 26/B, Debrecen, H-4028, Hungary.
István SzászPublic Health Research Institute, University of Debrecen, Kassai St 26/B, Debrecen, H-4028, Hungary.
Róza ÁdányPublic Health Research Institute, University of Debrecen, Kassai St 26/B, Debrecen, H-4028, Hungary.
Margit BalazsPublic Health Research Institute, University of Debrecen, Kassai St 26/B, Debrecen, H-4028, Hungary. balazs.margit@sph.unideb.hu.ORCID http://orcid.org/0000-0002-4246-2321
University of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major aim was to compare the gene expression signature of 2D and 3D cultured BRAFV600E mutant melanoma cell lines. We successfully developed BRAF-drug resistant cell lines from paired primary/metastatic melanoma cell lines in both 2D and 3D in vitro cultures. Using Affymetrix Human Gene 1.0 ST arrays, we determined the gene expression pattern of all cell lines. Our analysis revealed 1049 genes (562 upregulated and 487 downregulated) that were differentially expressed between drug-sensitive cells grown under different cell cultures. Pathway analysis showed that the differently expressed genes were mainly associated with the cell cycle, p53, and other cancer-related pathways. The number of upregulated genes (72 genes) was remarkably fewer when comparing the resistant adherent cells to cells that grow in 3D, and were associated with cell adhesion molecules and IGF1R signalling. Only 1% of the upregulated and 5.6% of the downregulated genes were commonly altered between the sensitive and the resistant spheroids. Interestingly, we found several genes (BNIP3, RING1 and ABHD4) with inverse expression signature between sensitive and resistant spheroids, which are involved in anoikis resistance and cell cycle regulation. In summary, our study highlights gene expression alterations that might help to understand the development of acquired resistance in melanoma cells in tumour tissue.

Indexed as

Spheroids, CellularTumor Cells, CulturedCell Culture TechniquesDrug Resistance, NeoplasmHumansMelanomaProtein Kinase InhibitorsProto-Oncogene Proteins B-rafTranscriptomeBRAF protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins B-raf2D and 3D cell cultureGene expression and BRAF inhibitor resistanceMelanoma cell linesSpheroids

Identifiers

PMID32613561
PMCPMC7471197
OpenAlexW3040538527

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.